Inflammation-related molecular signatures involved in the anticancer activities of brigatinib as well as the prognosis of EML4-ALK lung adenocarcinoma patient

Acta Pharmacologica Sinica, Published online: 15 February 2024; doi:10.1038/s41401-024-01230-xInflammation-related molecular signatures involved in the anticancer activities of brigatinib as well as the prognosis of EML4-ALK lung adenocarcinoma patient

Source: Acta Pharmacologica Sinica - February 15, 2024 Category: Drugs & Pharmacology Authors: Fu-jing Ge Xiao-yang Dai Yao Qiu Xiang-ning Liu Chen-ming Zeng Xiao-yuan Xu Yi-dan Chen Hong Zhu Qiao-jun He Ren-hua Gai Sheng-lin Ma Xue-qin Chen Bo Yang Source Type: research